Top Markets
#1 TENDIES TENDIES +37.02%
#2 Cash Cat Cash Cat +24.00%
#3 Asteroid Shiba Asteroid Shiba +16.86%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.30%
#6 Bluwhale Bluwhale +10.73%
#7 MarsCoin MarsCoin +8.62%
#8 ROLL ROLL +7.54%
#9 CARV CARV +7.24%
#10 Pyth Network Pyth Network +7.13%
Coin of the day
TENDIES TENDIES
설정
언어
한국어
통화
USD
테마
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
주식 순위 #16737
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
주가
$2.47
시가총액
$269.48M
변동 (1일)
-1.43%
변동 (1년)
-56.93%
국가
CN
거래 VISEN Pharmaceuticals (2561)

카테고리

Healthcare
VISEN Pharmaceuticals (2561)의 배당 수익률 기록
VISEN Pharmaceuticals (주식 심볼: 2561)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
VISEN Pharmaceuticals (2561)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
0.83%
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH